Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Outcomes after anti-BCMA CAR T-cells for multiple myeloma, a Retrospective analysis on behalf of the CTIWP and CMWP of the EBMT

Retrospective Studies

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Outcome of adult patients with HIV undergoing autologous or allogeneic haematopoietic cell transplantation

Retrospective Studies

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Résultats cliniques chez les patients adultes vivant avec le VIH après une greffe de cellules souches hématopoïétiques autologue ou allogénique

Études rétrospectives

Toutes les maladies

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Allogeneic stem cell transplantation for Follicular lymphoma, a benchmark study of the Lymphoma Working Party

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Yasmina Serroukh

Transplantation allogénique de cellules souches pour le lymphome folliculaire, une étude de référence du Lymphoma Working Party

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Yasmina Serroukh

Autologous Hematopoietic Stem Cell Transplantation for Natural Killer/T-cell Lymphoma as Consolidation and Relapse Treatment

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Philipp Berning

Retrospective analysis of different rabbit ATG brands on outcome and occurrence of acute and chronic GVHD in patients with aplastische anemia undergoing allogeneic transplantation

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Allogeneic - Related

Allogeneic - Unrelated

Principal investigator

Analyse rétrospective de l’impact de différentes marques d’ATG de lapin sur les résultats et la survenue de la GVH aiguë et chronique chez les patients atteints d’anémie aplasique ayant reçu une greffe allogénique

Études rétrospectives

Aplasie Médullaire

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Allogénique - Apparentée

Allogénique - Non apparentée

Principal investigator

The influence of pre-transplant immune dysregulation on transplant outcomes for combined immunodeficiencies and immune dysregulatory disorders

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

L'influence de la dysrégulation immunitaire pré-transplantation sur les résultats de la greffe pour les immunodéficiences combinées et les troubles dysrégulateurs du système immunitaire

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Thomas Fox & Emma Morris

Outcomes of pediatric patients with acute leukemias who received either post-transplant cyclophosphamide or a haploidentical transplant with TCR αβ/CD19+ lymphocyte depletion

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Myeloid Leukaemia (AML)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogeneic - Haploidentical

Principal investigator

Franco Locatelli

Résultats des patients pédiatriques atteints de leucémies aiguës ayant reçu soit du cyclophosphamide post-transplantation, soit une greffe haplo-identique avec déplétion des lymphocytes TCR αβ/CD19+

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Allogénique - Haplo-identique

Principal investigator

Franco Locatelli